Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein disulfide bonds in mucin and other glycoproteins are critical structural elements that maintain the three-dimensional architecture and viscoelastic properties of mucus (Source: PubMed, PMID: 25100604). Mucins, such as MUC5AC and MUC5B, are large, heavily glycosylated proteins that polymerize through the formation of intermolecular disulfide bonds between cysteine-rich domains (Source: UniProt). In diseases characterized by mucus hypersecretion and stasis, such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), these bonds contribute to the formation of thick, obstructive mucus plugs (Source: NIH, National Heart, Lung, and Blood Institute). Therapeutic intervention often involves the use of mucolytic agents, such as N-acetylcysteine, which act as reducing agents to break these disulfide bridges (Source: PubChem, CID 12035). By converting the disulfide bonds into free sulfhydryl groups, these drugs decrease the molecular weight and viscosity of the mucin polymers, facilitating easier clearance from the airways (Source: StatPearls, 'Mucolytics'). Beyond the respiratory tract, these bonds are also relevant in the gastrointestinal and ocular systems where mucus serves as a protective barrier (Source: Wikipedia, 'Mucin').
Reduction of disulfide bonds to free sulfhydryl groups, leading to the depolymerization of mucin networks and reduction of mucus viscosity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein disulfide bonds in mucin.